Miliary lung disease after intravesical bacillus Calmette-Guérin immunotherapy.
Clinical and radiologic findings in a 73-year-old man who developed a systemic illness while receiving intravesical bacillus Calmette-Guérin (BCG) immunotherapy for bladder cancer are presented. Thin-section chest computed tomographic findings included a diffuse pattern of small nodules consistent with miliary disease. Potential mechanisms explaining the pulmonary disease resulting from intravesical BCG treatment include a hypersensitivity reaction or actual BCG infection of the lungs.
Jasmer
R M
RM
Department of Medicine, University of California, San Francisco Medical Center 94143, USA.
McCowin
M J
MJ
Webb
W R
WR
D000368:Aged; D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000628:therapy; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D014057:Tomography, X-Ray Computed; D014391:Tuberculosis, Miliary / Q000000981:diagnostic imaging / Q000209:etiology* / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000209:etiology* / Q000382:microbiology; D001749:Urinary Bladder Neoplasms / Q000628:therapy
D001500:BCG Vaccine